{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:21:58Z","timestamp":1793294518720,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Define incidence and risk factors of osteonecrosis of the jaw (ONJ) and explore oral microbial signatures and host immune response as reflected by cytokine changes in saliva and serum in multiple myeloma (MM) patients on bisphosphate (BP) therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>A single center observational prospective study of MM patients (n = 110) on &amp;gt;2 years of BP, none had ONJ at enrollment. Patients were followed every 3 months for 18 months with clinical\/dental examination and serial measurements of inflammatory cytokines, bone turnover markers, and angiogenic growth factors. Oral microbiota was characterized by sequencing of 16S rRNA gene from saliva.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the study period 14 patients (13%) developed BRONJ, at a median of 5.7 years (95% CI: 1.9\u201312.0) from MM diagnosis. Chronic periodontal disease was the main clinically observed risk factor. Oral microbial profiling revealed lower bacterial richness\/diversity in BRONJ.\n                      <jats:italic>Streptococcus intermedius<\/jats:italic>\n                      ,\n                      <jats:italic>S. mutans<\/jats:italic>\n                      , and\n                      <jats:italic>S. perioris<\/jats:italic>\n                      were abundant in controls;\n                      <jats:italic>S. sonstellatus<\/jats:italic>\n                      and\n                      <jats:italic>S anginosus<\/jats:italic>\n                      were prevalent in BRONJ. In the saliva, at baseline patients who developed BRONJ had higher levels of MIP-1\u03b2; TNF-\u03b1 and IL-6 compared to those without BRONJ, cytokine profile consistent with M-1 macrophage activation. In the serum, patients with BRONJ have significantly lower levels of TGF beta and VEGF over the study period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Periodontal disease associated with low microbial diversity and predominance of invasive species with a proinflammatory cytokine profile leading to tissue damage and alteration of immunity seems to be the main culprit in pathogenesis of BRONJ.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2021.704722","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:46:13Z","timestamp":1624495573000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression"],"prefix":"10.3389","volume":"11","author":[{"given":"Ashraf Z.","family":"Badros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Meddeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Weikel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Milliron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Goloubeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Meiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel F.","family":"Mongodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: Mechanism of Action and Role in Clinical Practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and Zoledronate (Zometa) Induced Avascular Necrosis of the Jaws: A Growing Epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Double-Dummy, Randomised, Controlled, Phase 3 Study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2017.1348001","article-title":"Incidence of Osteonecrosis of the Jaw in Patients With Bone Metastases Treated Sequentially With Bisphosphonates and Denosumab","volume":"73","author":"Loyson","year":"2018","journal-title":"Acta Clin Belg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1749-6632.2010.05771.x","article-title":"Epidemiology and Risk Factors for Osteonecrosis of the Jaw in Cancer Patients","volume":"1218","author":"Hoff","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the Jaws Associated With the Use of Bisphosphonates: A Review of 63 Cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1248\/yakushi.19-00125","article-title":"[Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates]","volume":"140","author":"Endo","year":"2020","journal-title":"Yakugaku Zasshi"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, Risk Factors, and Outcomes of Osteonecrosis of the Jaw: Integrated Analysis From Three Blinded Active-Controlled Phase III Trials in Cancer Patients With Bone Metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.9300","article-title":"Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma","volume":"26","author":"Badros","year":"2008","journal-title":"J Clin Oncol"},{"key":"B13","first-page":"36","article-title":"Oral Complications in Cancer Patients: A Review of Practical Interventions in the Dental Setting","volume":"37","author":"Bissonnette","year":"2020","journal-title":"J Mich Dent Assoc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41413-020-0088-1","article-title":"Mitigating Osteonecrosis of the Jaw (ONJ) Through Preventive Dental Care and Understanding of Risk Factors","volume":"8","author":"Wan","year":"2020","journal-title":"Bone Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"CD012432","DOI":"10.1002\/14651858.CD012432.pub2","article-title":"Interventions for Managing Medication-Related Osteonecrosis of the Jaw","volume":"10","author":"Beth-Tasdogan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B16","article-title":"QIIME Allows Analysis of High-Throughput Community Sequencing Data","year":"2020","journal-title":"Nat Methods"},{"key":"B17","doi-asserted-by":"publisher","article-title":"Phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data","year":"","DOI":"10.1371\/journal.pone.0061217"},{"key":"B18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.oooo.2015.08.007","article-title":"Periodontal Disease Preceding Osteonecrosis of the Jaw (ONJ) in Cancer Patients Receiving Antiresorptives Alone or Combined With Targeted Therapies: Report of 5 Cases and Literature Review","volume":"120","author":"Nicolatou-Galitis","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.1038\/s41598-020-66412-z","article-title":"Influence of the Long-Term Use of Oral Hygiene Products Containing Stannous Ions on the Salivary Microbiome - A Randomized Controlled Trial","volume":"10","author":"Anderson","year":"2020","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2012.01916.x","article-title":"Molecular Profiling of Oral Microbiota in Jawbone Samples of Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"18","author":"Wei","year":"2012","journal-title":"Oral Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of Microbial Biofilms in Osteonecrosis of the Jaws Secondary to Bisphosphonate Therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037919","article-title":"Deep Sequencing of the Oral Microbiome Reveals Signatures of Periodontal Disease","volume":"7","author":"Liu","year":"2012","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12967-015-0568-z","article-title":"Systemic Immunity Shapes the Oral Microbiome and Susceptibility to Bisphosphonate-Associated Osteonecrosis of the Jaw","volume":"13","author":"Kalyan","year":"2015","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2014.05.002","article-title":"Important Aspects Regarding the Role of Microorganisms in Bisphosphonate-Related Osteonecrosis of the Jaws","volume":"59","author":"Boff","year":"2014","journal-title":"Arch Oral Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/omi.12056","article-title":"Molecular Pathogenicity of Streptococcus Anginosus","author":"Asam","year":"2014","journal-title":"Mol Oral Microbiol"},{"key":"B26","article-title":"Human Oral Microbiome Database: A Web Accessible Resource for Investigating Oral Microbe Taxonomic and Genomic Information","year":"2020","journal-title":"Database Oxford"},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1086\/338145","article-title":"Interaction Between Human Polymorphonuclear Leukocytes and Streptococcus Milleri Group Bacteria","volume":"185","author":"Wanahita","year":"2002","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2017.01.006","article-title":"Role of Microbiological Culture and Polymerase Chain Reaction (PCR) of Actinomyces in Medication-Related Osteonecrosis of the Jaw (MRONJ)","volume":"45","author":"Panya","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nri2448","article-title":"Exploring the Full Spectrum of Macrophage Activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2735","article-title":"Macrophages: Their Emerging Roles in Bone","volume":"30","author":"Sinder","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8917804","article-title":"Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders","volume":"2018","author":"Parisi","year":"2018","journal-title":"J Immunol Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-Mediated M1\/M2 Macrophage Alteration Contributes to Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00461-16","article-title":"Proinflammatory M1 Macrophages Inhibit Rankl-Induced Osteoclastogenesis","volume":"84","author":"Yamaguchi","year":"2016","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.03.031","article-title":"Vasculature Submucosal Changes at Early Stages of Osteonecrosis of the Jaw (ONJ)","volume":"123","author":"Gkouveris","year":"2019","journal-title":"Bone"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-020-09961-2","article-title":"Zoledronate Inhibits Osteoclast Differentiation Via Suppressing Vascular Endothelial Growth Factor Receptor 2 Expression","volume":"58","author":"Nakagawa","year":"2020","journal-title":"Biochem Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e41065","DOI":"10.1371\/journal.pone.0041065","article-title":"Zoledronate Inhibits Ischemia-Induced Neovascularization by Impairing the Mobilization and Function of Endothelial Progenitor Cells","volume":"7","author":"Tsai","year":"2012","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2985","article-title":"IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-\u03b2-Mediated Collagen Expression","volume":"32","author":"Kim","year":"2017","journal-title":"J Bone Miner Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.704722\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:46:16Z","timestamp":1624495576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.704722\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":37,"alternative-id":["10.3389\/fonc.2021.704722"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.704722","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"article-number":"704722"}}